Attached files

file filename
EX-99 - PRESS RELEASE - AASTROM BIOSCIENCES INCnewsrelease.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 8, 2012 


Aastrom Biosciences, Inc.
(Exact name of registrant as specified in its charter)


Michigan

0-22025

94-3096597
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer Identification No.)



24 Frank Lloyd Wright Drive
P.O. Box 376
Ann Arbor, Michigan

48106
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:   1-800-556-0311



________________________________________________________________________________
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    [   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition.

On November 8, 2012 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

    Exhibit 99.1.       Press release dated November 8, 2012


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Aastrom Biosciences, Inc.
(Registrant)


November 8, 2012
(Date)
  /s/   TIMOTHY M. MAYLEBEN
Timothy M. Mayleben
Chief Executive Officer and President


  Exhibit Index
  99.1 Press release dated November 8, 2012